Blood Cell Recycling During Pancreatic Cancer Surgery
Part of Blood & lymphatic, Cancer, Digestive system clinical trials.
This trial tests whether recycling a patient's own blood cells during pancreatic cancer surgery is safe and helpful. Instead of discarding blood lost during surgery, doctors will collect, clean, and return it to you to reduce the need for donor blood transfusions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have pancreatic adenocarcinoma (cancer) confirmed by biopsy or pathology
- You are at least 18 years old and able to give informed consent
- You are healthy enough for major surgery (ECOG performance status 0–2)
- Your blood counts and kidney/liver function meet specific thresholds
- You finished any prior chemotherapy or radiation at least 14 days ago and recovered from side effects
- You do not have metastatic cancer (cancer spread to distant organs) or active infections
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how tiny particles in blood (“exosomes”) carry signals between cells in people having pancreatic surgery. The goal is to understand these signals in different pancreatic conditions and treatment situations, which may help future care.
This trial tests whether giving back a patient's own platelets and red blood cells during heart surgery can reduce bleeding and the need for donor blood transfusions. It is for people having certain types of high-risk heart surgery with a heart-lung machine.
This trial tests whether collecting and re-infusing your own blood during heart surgery reduces the need for donor blood transfusions. It's for adults having planned bypass surgery with a heart-lung machine.
This trial looks at how a device that collects and reuses your own blood during heart surgery works. It may help reduce the need for donated blood.
This trial tests if a machine that collects and reuses blood during heart surgery can help patients avoid needing donor blood transfusions. It is for people having a first-time coronary bypass or heart valve surgery.
This trial studies a new blood test that looks for cancer-specific immune cells after surgery for pancreatic cancer. It aims to see if the test can detect any remaining cancer cells earlier than standard methods, which could help guide further treatment decisions.
Hear when a new Pancreatic Surgery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.